![]() ![]() Neutralizing Antibodies for Pre-Exposure Prophylaxis: A remark was added to the recommendation regarding resistance of tixagevimab/cilgavimab (Evusheld) in the US.They were provided here for immediate use and were later integrated into the website on Februas part of Version 10.2.0. The following recommendation were updated based on newly available literature and approvals. No changes have been made to the current recommendation. Version 10.2.1 has been released and includes updated evidence summaries and clarified remarks on the use of molnupiravir. This update has been endorsed by the Society for Healthcare Epidemiology of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Additionally, this section includes updated remarks for the existing recommendation on the use of convalescent plasma for ambulatory patients with mild-to-moderate COVID-19 at high risk for progression to severe disease who have no other treatment options. This update has been endorsed by the Society for Healthcare Epidemiology of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.ĭownload Cite Update History April 11, 2023Ĭonvalescent Plasma (PDF): A new recommendation was developed against the routine use of convalescent plasma among immunocompromised patients hospitalized with COVID-19. Nirmatrelvir/Ritonavir (PDF): This section includes updated remarks for the existing recommendation on the use of nirmatrelvir/ritonavir for ambulatory patients with mild-to-moderate COVID-19 at high risk for progression to severe disease.Anakinra (PDF): This section has been added and includes a new recommendation against the routine use of anakinra among hospitalized patients with severe COVID-19.This update will be fully integrated into this webpage soon it is provided here for immediate use. The following sections have been updated based on newly available literature and approvals. Mustafa,** Shahnaz Sultan,** Yngve Falck-Ytter** Morgan,** Amy Hirsch Shumaker, Lindsey Baden, Vincent Chi-Chung Cheng, Kathryn M. Medical Education Community of PracticeĪdarsh Bhimraj,* Rebecca L.Fellows-In-Training Career & Education Center.myIDSA Practice Managers Community Opt-in Form.Antimicrobial Stewardship Centers of Excellence Program. ![]() The eligible costs for the awards are $179,027,466.46 and $16,955,146.69 with a federal share of 134,270,599.85 and $12,716,360.02 respectively.įEMA’s Public Assistance Program provides funding to state and local government jurisdictions and eligible private non-profits for the repair, replacement, or restoration of disaster-damaged infrastructure as well as costs incurred for debris removal, disaster cleanup and emergency actions taken to protect lives or property. ![]() This agency will continue to work tirelessly to meet the needs of our communities.”įEMA provides a 75 percent federal share of eligible reimbursable expenses for these projects. Under the direction of Governor JB Pritzker, the Illinois Emergency Management Agency has gone to great lengths to procure PPE for our frontline healthcare workers, first responders and our state’s critical workforce. “Studies show wearing personal protective equipment, such as a face mask, is critical to slow the spread of COVID-19 from one person to another. “The State of Illinois remains steadfast in its commitment to save lives during this pandemic,” said IEMA Director Alicia Tate-Nadeau. “These grant funds helped ensure PPE was available statewide to protect essential workers, first responders and others.” Sligh, acting regional administrator, FEMA Region 5. “FEMA’s Public Assistance Program is an important resource for states affected by COVID-19,” said Kevin M. A major objective of the Illinois response to the public health emergency was to ensure that hospitals, medical facilities, response organizations, public health and safety agencies and other essential functions had adequate PPE, supplies and equipment to respond and continue providing essential and critical services. PPE was stored in state operated warehouses for statewide distribution in response to resource requests submitted by eligible partners. In response to COVID-19, the Illinois Emergency Management Agency (IEMA) utilized contracts to purchase and distribute personal protective equipment (PPE) statewide to reduce the threat of COVID-19. ![]() This grant funding is part of the recovery efforts in response to the federal disaster declaration of March 31, 2020. Department of Homeland Security’s Federal Emergency Management Agency (FEMA) and Illinois Emergency Management Agency (IEMA) announced this week that two grants totaling $146,986,960 have been made available in federal disaster aid to reimburse IEMA for emergency protective measures as a result of the COVID-19 pandemic. ![]()
0 Comments
Leave a Reply. |